Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.
Paying user area
Try for free
Pfizer Inc. pages available for free this week:
- Income Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Solvency Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Enterprise Value to FCFF (EV/FCFF)
- Present Value of Free Cash Flow to Equity (FCFE)
- Selected Financial Data since 2005
- Return on Equity (ROE) since 2005
- Price to Sales (P/S) since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Pfizer Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Pfizer Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
US$ in millions
Based on: 10-Q (reporting date: 2026-03-29), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-28), 10-Q (reporting date: 2025-06-29), 10-Q (reporting date: 2025-03-30), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-29), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-10-01), 10-Q (reporting date: 2023-07-02), 10-Q (reporting date: 2023-04-02), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-02), 10-Q (reporting date: 2022-07-03), 10-Q (reporting date: 2022-04-03), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-03), 10-Q (reporting date: 2021-07-04), 10-Q (reporting date: 2021-04-04).
The overall financial structure exhibits a significant expansion in total liabilities and equity, growing from 158.8 billion USD in April 2021 to a peak of 226.5 billion USD in December 2023, before stabilizing around 207.6 billion USD by March 2026. This growth is primarily driven by a substantial increase in long-term debt and a corresponding shift in the company's capital composition.
- Long-Term Debt and Noncurrent Liabilities
- A pivotal shift in the capital structure occurred in July 2023, where long-term debt, excluding the current portion, jumped from approximately 31.7 billion USD to 61.4 billion USD. This elevated level of debt remained relatively constant, fluctuating between 57.4 billion USD and 61.6 billion USD through March 2026. Consequently, noncurrent liabilities rose from a range of 58 billion to 63 billion USD in the 2021-2022 period to a higher plateau between 79 billion and 89 billion USD from 2023 onwards.
- Current Liabilities and Short-Term Obligations
- Current liabilities showed significant volatility, peaking at 47.8 billion USD in December 2023. Short-term borrowings experienced sharp fluctuations, notably spiking to 11.9 billion USD in June 2024 before decreasing to 3.9 billion USD by March 2026. Other current liabilities remained a substantial component of the short-term profile, generally fluctuating between 17 billion and 28 billion USD throughout the analyzed period.
- Shareholders' Equity and Retained Earnings
- Total equity experienced a period of growth, rising from 68.9 billion USD in April 2021 to a peak of 101.2 billion USD in April 2023. Following this peak, equity entered a phase of moderate decline and stabilization, ending at 90.4 billion USD in March 2026. Retained earnings followed a similar trajectory, peaking at 131.1 billion USD in April 2023 before contracting to 117.2 billion USD by the end of the period.
- Capital Management and Treasury Stock
- A consistent increase in the magnitude of treasury stock is observed, moving from negative 111.3 billion USD in April 2021 to negative 115.2 billion USD in March 2026. This indicates a sustained commitment to share repurchases. Additionally, accumulated other comprehensive loss widened from 4.7 billion USD in early 2021 to a peak of 8.6 billion USD in March 2024, before recovering slightly to 7.2 billion USD by March 2026.
- Total Liability and Equity Trends
- The total balance sheet expanded by approximately 30% between April 2021 and March 2026. While the initial growth was balanced between equity and liabilities, the later stages of the period were characterized by a higher reliance on long-term debt to sustain the expanded asset base, as evidenced by the stabilization of total equity at levels below its 2023 peak despite the overall increase in total liabilities.